Nuveen Asset Management, LLC Cytokinetics Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 383,176 shares of CYTK stock, worth $18.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

383,176

Previous 355,141 7.89%

Holding current value

$18.8 Million

Previous $19.2 Million 5.15%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $1.44 Million - $1.69 Million	28,035 Added 7.89%	383,176 $20.2 Million
Q2 2024 Aug 09, 2024	SELL	$47.86 - $75.05 $6.91 Million - $10.8 Million	-144,460 Reduced 28.92%	355,141 $19.2 Million
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $9.95 Million - $16.9 Million	156,000 Added 45.4%	499,601 $35 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $699,498 - $2.17 Million	-26,023 Reduced 7.04%	343,601 $28.7 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $72,530 - $90,133	2,462 Added 0.67%	369,624 $10.9 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $725,892 - $906,809	22,253 Added 6.45%	367,162 $12 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $490,291 - $671,799	-14,697 Reduced 4.09%	344,909 $12.1 Million
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $98,260 - $140,399	-2,747 Reduced 0.76%	359,606 $16.5 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $51,797 - $73,274	1,344 Added 0.37%	362,353 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $3.48 Million - $5.01 Million	102,426 Added 39.61%	361,009 $14.2 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $50,766 - $78,522	-1,707 Reduced 0.66%	258,583 $9.2 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $764,596 - $1.03 Million	-22,259 Reduced 7.88%	260,290 $9.51 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $465,669 - $897,681	25,117 Added 9.76%	282,549 $9.58 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $760,608 - $1.04 Million	-38,434 Reduced 12.99%	257,432 $5.1 Million
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $1.36 Million - $1.88 Million	-73,338 Reduced 19.86%	295,866 $6.88 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $2.68 Million - $5.02 Million	-175,396 Reduced 32.21%	369,204 $7.67 Million
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $5.1 Million - $7.18 Million	247,892 Added 83.55%	544,600 $11.8 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $559,339 - $1.24 Million	50,165 Added 20.35%	296,708 $6.99 Million
Q1 2020 May 14, 2020	BUY	$8.75 - $16.3 $4,305 - $8,019	492 Added 0.2%	246,543 $2.91 Million
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $1.39 Million - $2.06 Million	-174,381 Reduced 41.48%	246,051 $2.61 Million
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $2.43 Million - $3.2 Million	224,569 Added 114.66%	420,432 $4.79 Million
Q2 2019 Aug 15, 2019	BUY	$7.95 - $11.25 $1.56 Million - $2.2 Million	195,863 New	195,863 $2.2 Million

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Cytokinetics Inc Transaction History